Goblet cell adenocarcinoma of the appendix
Prepared with OnCo (onco.cc/prep/goblet-cell-adenocarcinoma/). Orientation, not medical advice; your team knows your case.
My details
What I know, what is unclear, changes to discuss
Saved in this browserMy questions
16 on the sheet- 1.What is my exact diagnosis, stage, and grade, and which tests established them?
- 2.Which biomarkers have been tested on my tumour (for example WHO 2019 grade, TNM stage after right hemicolectomy, Synaptophysin and chromograninwith mucin stains, Somatostatin receptor status, CEA, CA 19-9 and CA-125 for surveillance), and what were the results?
- 3.Which subtype is my cancer, and does that change the recommended treatment?
- 4.Is germline (inherited) genetic testing recommended for me or my family?
- 5.For my situation (diagnosis), which of the standard options do you recommend and why?
- 6.For my situation (localised disease), which of the standard options do you recommend and why?
- 7.Am I a candidate for FOLFOX (5-FU, leucovorin, oxaliplatin), CAPOX (capecitabine, oxaliplatin), and what side effects should I expect?
- 8.For my situation (peritoneal metastases), which of the standard options do you recommend and why?
- 9.Am I a candidate for FOLFOX (5-FU, leucovorin, oxaliplatin), and what side effects should I expect?
- 10.For my situation (metastatic disease), which of the standard options do you recommend and why?
- 11.Am I a candidate for FOLFOX (5-FU, leucovorin, oxaliplatin), CAPOX (capecitabine, oxaliplatin), FOLFIRI (5-FU, leucovorin, irinotecan), and what side effects should I expect?
- 12.Are there clinical trials I could join, for example of FOLFOX (5-FU, leucovorin, oxaliplatin), HIPEC / PIPAC (intraperitoneal chemotherapy)?
- 13.Would a second opinion at a high-volume centre change anything, and can you help arrange it?
- 14.What supportive care (symptom control, nutrition, exercise, mental health, financial help) is available from the start?
- 15.I read that “No prospective trial has ever been conducted; all treatment is extrapolated”. How does that affect my plan?
- 16.I read that “The benefit of adjuvant chemotherapy in grade 1 node-negative disease is unknown”. How does that affect my plan?
The words I may hear
- HIPEC (hyperthermic intraperitoneal chemotherapy): After surgeons remove all visible tumour from the abdominal lining, the abdomen is bathed for 60-90 minutes in heated chemotherapy to kill the microscopic cells left behind.
- Colectomy: Removing the part of the colon containing the cancer along with its blood supply and lymph nodes, then joining the ends.
- Peritoneal metastasis: Spread across the lining of the abdomen, the most common way stomach cancer recurs and the hardest to treat.
- Endoscopy (EGD, EUS, ERCP): Looking inside a hollow organ with a camera on a flexible tube, taking biopsies and sometimes treating on the spot.
- Lymphadenectomy (lymph node dissection): Surgically removing the lymph nodes that drain a tumour, both to stage the cancer and to clear any spread.
Tests and results to bring
Diagnosis: Expert pathology review with WHO 2019 grading; CT of chest, abdomen and pelvis; colonoscopy; tumour markers; no somatostatin receptor imaging is needed.
Biomarker results to ask for: WHO 2019 grade (proportion of low-grade tubular pattern), TNM stage after right hemicolectomy, Synaptophysin and chromogranin (focal) with mucin stains (diagnosis), Somatostatin receptor status (negative; not a target), CEA, CA 19-9 and CA-125 for surveillance, Peritoneal cancer index where peritoneal disease is present.
Scans and tests linked to this cancer: CT (computed tomography), Histopathology & immunohistochemistry.
Bring copies of scan reports, pathology and blood results, and a list of every medicine and supplement.
The treatments I may be offered
- Localised disease: Right hemicolectomy with lymphadenectomy for all grades; oophorectomy considered in postmenopausal women; adjuvant FOLFOX or CAPOX for node-positive or grade 2 to 3 disease. (Colectomy, Lymphadenectomy (lymph node dissection), FOLFOX (5-FU, leucovorin, oxaliplatin), CAPOX (capecitabine, oxaliplatin))
- Peritoneal metastases: Cytoreductive surgery with HIPEC in fit patients with limited disease, with perioperative systemic chemotherapy. (HIPEC / PIPAC (intraperitoneal chemotherapy), HIPEC (hyperthermic intraperitoneal chemotherapy), Peritoneal metastasis, FOLFOX (5-FU, leucovorin, oxaliplatin))
- Metastatic disease: FOLFOX or CAPOX, then FOLFIRI, as for colorectal adenocarcinoma; somatostatin analogues and platinum-etoposide are not used. (FOLFOX (5-FU, leucovorin, oxaliplatin), CAPOX (capecitabine, oxaliplatin), FOLFIRI (5-FU, leucovorin, irinotecan))
From the standard of care recorded for this cancer; which apply depends on your stage and biomarkers. Ask which the team recommends and why.